Dear Duchenne Community – Since day one, Solid Biosciences has been focused on developing meaningful therapies for patients with Duchenne muscular dystrophy. This cause is deeply embedded in our organization, which was founded by individuals impacted by Duchenne. Today, we are pleased to announce that Solid received clearance by the U.S. Food and Drug Administration ... Read more
